2020 - IHE

Willis M, Asseburg C, Slee A, Nilsson A, Neslusan C Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data Diabetes Therapy 2020;11(11):2657-2676
DOI: https://doi.org/10.1007/s13300-020-00923-w
Lindgren P, Löfvendahl S, Brådvik G, Weiland O. Reduced work absenteeism in patients with hepatitis C treated with second-generation direct-acting antivirals Journal of Viral Hepatitis, 2020 (e-pub ahead of print )
DOI: https://doi.org/10.1111/jvh.13398
Si L, Willis M, Asseburg C, Nilsson A, Tew M, Clarke P M, Lamotte M, Ramos M, Shao H, Shi L, Zhang P, McEwan P, Ye W, Herman W H, Kuo S, Isaman DJ, Schramm W, Sailer F, Brennan A, Pollard D, Smolen H J, Leal J, Gray A, Patel R, Feenstra T, Palmer A J Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge Value in Health 2020;23(9):1163-1170
DOI :https://doi.org/10.1016/j.jval.2020.04.1832
Omar M I, Roobol M J. Ribal M J, Abbott T, Agapow P-M, Araujo S, Asiimwe A, Auffray C, Balaur I, Beyer K, Bernini C, Bjartell A, Briganti A, Butler-Ransohoff J-E, Campi R, Cavelaars M, De Meulder B, Devecseri, Voss MD, Dimitropoulos K, Evans-Axelsson S, Franks B, Fullwood L, Horgan D, Smith E J, Kiran A, Kivinummi K, Lambrecht M, Lancet D, Lindgren P, MacLennan S, MacLennan S, Nogueira M M, Moen F, Moinat M, Papineni K, Reich C, Kristin Reiche, Rogiers S, Sartini C, van Bochove K, van Diggelen F, Van Hemelrijck M, Van Poppel H, Zong J, N’Dow J & The PIONEER Consortium Introducing PIONEER: a project to harness big data in prostate cancer research Nature Reviews Urology, 2020; 17: 351–362
DOI: https://doi.org/10.1038/s41585-020-0324-x
Lindgren P, Althin R Something borrowed, something new: measuring hospital performance in the context of value based health care The European Journal of Health Economics (online ahead of print)
DOI: doi.org/10.1007/s10198-020-01209-5
Hjelmgren J, Nilsson K, Birgegård G JAK2 V617F as a Marker for Long-Term Disease Progression and Mortality in Polycythemia Vera and its Role in Economic Modeling Journal of Health Economic and Outcomes Research, 2020;7(1):61-70
DOI: 10.36469/jheor.2020.13083
Willis M, Fridhammar A, Gundgaard J, Nilsson A, Johansen P Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM PharmacoEconomics 2020;38(9):953-969
DOI: https://doi.org/10.1007/s40273-020-00922-6
Persson U, Norlin J Opportunities and challenges of an innovative payment model for Advanced Therapy Medicinal Products in Sweden -A hypothetical example in the treatment of β-thalassemia IHE Report 2020:3, Lund: IHE, Sweden, 2020.
Keel G Counting What Counts: Time-Driven Activity-Based Costing in Health Care Thesis 2020. Stockholm: Karolinska Institutet, Medical management center, Department of learning, informatics, management & ethics; Sweden.
ISBN: 978-91-7831-817-9
Persson S, Johansen P, Andersson E, Lindgren P, Thielke D, Larsen Thorsted B, Jendle J & Steen Carlsson K Days absent from work due to complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden Diabetes, Obesity and Metabolism (DOM), 2020;22(9):1586-1597
First published: 24 April 2020
DOI: https://doi.org/10.1111/dom.14070

Back »Next »